Mirna Therapeutics To Collaborate With M. D. Anderson On MiRNA Prostate Cancer Therapeutics (Medical News Today) PDF Print

Mirna Therapeutics ("Mirna"), a wholly owned subsidiary of Asuragen, Inc., and The University of Texas M. D. Anderson Cancer Center Science Park Research Center in Smithville have entered into a collaboration to investigate microRNAs in human prostate cancer. The principal investigators for the study are Dean Tang, M.D., Ph.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.